References
- BurtonKAAshackKAKhachemouneACutaneous squamous cell carcinoma: a review of high-risk and metastatic diseaseAm J Clin Dermatol201617549150827358187
- BroughamNDTanSTThe incidence and risk factors of metastasis for cutaneous squamous cell carcinoma – implications on the T-classification systemJ Surg Oncol2014110787688225088537
- ParekhVSeykoraJTCutaneous squamous cell carcinomaClin Lab Med201737350352528802498
- YuXLiZThe role of miRNAs in cutaneous squamous cell carcinomaJ Cell Mol Med20162013926508273
- AmbrosiniGAdidaCAltieriDCA novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNat Med1997389179219256286
- PeeryRCLiuJYZhangJTTargeting survivin for therapeutic discovery: past, present, and future promisesDrug Discov Today201722101466147728577912
- MitaACMitaMMNawrockiSTGilesFJSurvivin: key regulator of mitosis and apoptosis and novel target for cancer therapeuticsClin Cancer Res200814165000500518698017
- PhilchenkovAMiuraKThe IAP protein family, SMAC mimetics and cancer treatmentCrit Rev Oncog2016213–418520227915971
- BongiovanniLMüllerEJdella SaldaLSurvivin in skin pathologiesExp Dermatol201120645746321585553
- CheungCHChengLChangKYChenHHChangJYInvestigations of survivin: the past, present and futureFront Biosci201116952961
- KhanZKhanAAYadavHPrasadGBisenPSSurvivin, a molecular target for therapeutic interventions in squamous cell carcinomaCell Mol Biol Lett201722828536639
- LiuHQWangYHWangLLHaoMP16INK4A and survivin: diagnostic and prognostic markers in cervical intraepithelial neoplasia and cervical squamous cell carcinomaExp Mol Pathol2015991444925910412
- LeeJPChangKHHanJHRyuHSSurvivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factorsInt J Gynecol Cancer200515111311915670305
- SinghCKNdiayeMAAhmadNResveratrol and cancer: challenges for clinical translationBiochim Biophys Acta2015185261178118525446990
- CarterLGD’OrazioJAPearsonKJResveratrol and cancer: focus on in vivo evidenceEndocr Relat Cancer2014213R209R22524500760
- JangMCaiLUdeaniGOCancer chemopreventive activity of resveratrol, a natural product derived from grapesScience199727552972182208985016
- AluyenJKTonQNTranTResveratrol: potential as anticancer agentJ Diet Suppl201291455622432802
- BermanAYMotechinRAWiesenfeldMYHolzMKThe therapeutic potential of resveratrol: a review of clinical trialsNPJ Precis Oncol2017113528989978
- LeeJSOhEYooJYAdenovirus expressing dual c-Met-specific shRNA exhibits potent antitumor effect through autophagic cell death accompanied by senescence-like phenotypes in glioblastoma cellsOncotarget2015664051406525726528
- YuHXiongJZhangRNdk, a novel host-responsive regulator, negatively regulates bacterial virulence through quorum sensing in Pseudomonas aeruginosaSci Rep201662868427345215
- LiYWangXQZhangLA SNP in pri-miR-10a is associated with recurrent spontaneous abortion in a Han-Chinese populationOncotarget2016778208822226824181
- AggarwalBBBhardwajAAggarwalRSRole of resveratrol in prevention and therapy of cancer: preclinical and clinical studiesAnticancer Res2004245A2783284015517885
- JiangZChenKChengLResveratrol and cancer treatment: updatesAnn N Y Acad Sci201714031596928945938
- WangKBremsJJGamelliRLHoltermanAXSurvivin signaling is regulated through nuclear factor-kappa B pathway during glycochen-odeoxycholate-induced hepatocyte apoptosisBiochim Biophys Acta20101803121368137520816704
- ZhangYHuangHZhouHActivation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancerCancer2014120203208321824925528
- ParikhSAPatelVARatnerDAdvances in the management of cutaneous squamous cell carcinomaF1000 Prime Rep2014670
- TamCWongJHCheungRCFZuoTNgTBTherapeutic potentials of short interfering RNAsAppl Microbiol Biotechnol2017101197091711128791440
- SelvamCMutisyaDPrakashSRangannaKThilagavathiRTherapeutic potential of chemically modified siRNA: recent trendsChem Biol Drug Des201790566567828378934